A significant increase in skeletal muscle mass and myofiber area was observed in apelin administration (Table 3); therefore, we confirmed that apelin had an inhibitory effect on skeletal muscle atrophy, resulting from CKD. The gene discussed is APLN; the disease is chronic kidney disease.